首页> 外文期刊>Acta Virologica: International Journal >Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
【24h】

Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.

机译:日本口服强力脊髓灰质炎脊髓灰质炎病毒1株口服口服脊髓灰质炎病毒疫苗的疗效评估。

获取原文
获取原文并翻译 | 示例
       

摘要

Virulent Sabin-like poliovirus (VSLP) was isolated from river and sewage waters between October 1993 and September 1995 in Toyama Prefecture, Japan (Yoshida et al., Lancet 356, 1461-1463, 2000). In this study, to assess the possibility of an epidemic of poliomyelitis caused by a VSLP in Japan under the current vaccination policy of administration of live attenuated oral poliovirus vaccine (OPV), we determined titers of serum neutralizing antibodies to poliovirus 1 (PV-1) strains Sabin (vaccine strain), Mahoney (wild-type strain) and G4-12 (VSLP) in various groups of residents of Toyama Prefecture, Japan. The seropositivity and geometric mean neutralizing antibody titers against these strains in the individuals who obtained two doses of OPV were 99.1%, 94.5% and 95.5%, respectively, and 564, 186 and 194, respectively. Although the antibody titers to G4-12 were lower compared with those to Sabin, these results indicate that the OPV vaccination policy in Japan has been effective in preventing poliomyelitis caused by VSLPs. These results also suggest that (i) an epidemic of poliomyelitis caused by a VSLP has not occurred in Japan due to herd immunity, and (ii) the possibility of reemergence of VSLPs will be prevented if sufficient herd immunity is acquired immediately after completion of the OPV vaccination in accordance with the poliomyelitis eradication program.
机译:在1993年10月至1995年9月之间,在日本富山县的河流和污水中分离出了强毒的萨宾样脊髓灰质炎病毒(Yoshida等,Lancet 356,1461-1463,2000)。在这项研究中,为了评估根据现行的减毒口服脊髓灰质炎病毒口服疫苗疫苗接种政策,日本VSLP引起的脊髓灰质炎流行的可能性,我们确定了针对脊髓灰质炎病毒1(PV-1)的血清中和抗体的效价)日本富山县居民中的各种菌株Sabin(疫苗菌株),Mahoney(野生型菌株)和G4-12(VSLP)。在两次接种OPV的个体中,针对这些菌株的血清阳性和几何平均中和抗体效价分别为99.1%,94.5%和95.5%,分别为564、186和194。尽管与Sabin相比,针对G4-12的抗体滴度较低,但这些结果表明,日本的OPV疫苗接种政策已有效预防VSLP引起的脊髓灰质炎。这些结果还表明(i)在日本,由于牛群免疫性而没有发生由VSLP引起的脊髓灰质炎流行,并且(ii)如果在完成牛群免疫后立即获得足够的牛群免疫性,将防止VSLP再次出现的可能性。按照根除脊髓灰质炎计划进行的OPV疫苗接种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号